Vergent Bioscience, Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-04. The offering totals $22.1M, of which $21.5M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Samuel Banks | Director | Toronto, A6 |
| Jeffrey Julkowski | Director | MINNEAPOLIS, MN |
| Margo Shoup | Director | MINNEAPOLIS, MN |
| Jeffrey Julkowski | Promoter | MINNEAPOLIS, MN |
| Douglas Kohrs | Director | DALLAS, TX |
| Ryan Egeland | Director | Maple Grove, MN |
| Bobby T Helmedag | Director | Minneapolis, MN |
| Jeffrey T Yurecko | Executive Officer | Minneapolis, MN |
| Anita T Watkins | Director | Minneapolis, MN |
| John T Santini, Jr. | Director | Minneapolis, MN |
| John T Santini, Jr. | Executive Officer | Minneapolis, MN |
| Raymond T Wong | Director | Minneapolis, MN |
| Douglas T Kohrs | Director | Minneapolis, MN |
| Jeff Julkowski | Director | Minneapolis, MN |
| Raymond Wong | Director | Hong Kong, K3 |
| Jeffrey Yurecko | Executive Officer | Minneapolis, MN |
| John Santini | Director | Minneapolis, MN |
| John Santini | Executive Officer | Minneapolis, MN |
| Anita Watkins | Director | Minneapolis, MN |
| Samuel Dean Banks | Director | Minneapolis, MN |
| Anita Wilson | Director | Minneapolis, MN |
| Raymond Dean Wong | Director | MINNEAPOLIS, MN |
| Ryan Dean Egeland | Director | MINNEAPOLIS, MN |
| Samuel Dean Banks | Director | MINNEAPOLIS, MN |
| Douglas Dean Kohrs | Director | MINNEAPOLIS, MN |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-10-20 | D | $32.0M | $18.7M |
| 2025-02-18 | D | $5.0M | $3.8M |
| 2025-02-18 | D/A | $5.0M | $3.8M |
| 2021-11-22 | D | $2.0M | $1.2M |
| 2020-09-23 | D/A | $11.9M | $11.9M |
| 2019-02-22 | D/A | $9.7M | $9.7M |
| 2018-06-01 | D | $8.7M | $8.7M |